Dezerv

Fund Overview

Fund Size

Fund Size

₹2,312 Cr

Expense Ratio

Expense Ratio

1.97%

ISIN

ISIN

INF769K01EA2

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

02 Jun 2018

About this fund

Mirae Asset Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund schemes offered by Mirae Asset India Mutual Fund. This fund has been in existence for 6 years, 1 months and 23 days, having been launched on 02-Jun-18.
As of 24-Jul-24, it has a Net Asset Value (NAV) of ₹34.79, Assets Under Management (AUM) of 2312.48 Crores, and an expense ratio of 1.97%.
  • Mirae Asset Healthcare Fund Regular Growth has given a CAGR return of 22.50% since inception.
  • The fund's asset allocation comprises around 98.83% in equities, 0.00% in debts, and 1.16% in cash & cash equivalents.
  • You can start investing in Mirae Asset Healthcare Fund Regular Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+43.83%

+45.58% (Cat Avg.)

3 Years

+14.40%

+14.39% (Cat Avg.)

5 Years

+28.67%

+26.53% (Cat Avg.)

Since Inception

+22.50%

(Cat Avg.)

Portfolio Summaryas of 30th June 2024

Equity2,285.4 Cr98.83%
Others27.07 Cr1.17%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity298.36 Cr12.90%
Cipla LtdEquity219.43 Cr9.49%
Aurobindo Pharma LtdEquity215.88 Cr9.34%
Dr Reddy's Laboratories LtdEquity172.03 Cr7.44%
Apollo Hospitals Enterprise LtdEquity141.28 Cr6.11%
Divi's Laboratories LtdEquity104.99 Cr4.54%
Lupin LtdEquity104.75 Cr4.53%
Glenmark Pharmaceuticals LtdEquity92.9 Cr4.02%
Krishna Institute of Medical Sciences LtdEquity92.83 Cr4.01%
Gland Pharma LtdEquity90.93 Cr3.93%
Torrent Pharmaceuticals LtdEquity89.64 Cr3.88%
Fortis Healthcare LtdEquity77.69 Cr3.36%
J.B. Chemicals & Pharmaceuticals LtdEquity75.48 Cr3.26%
Max Healthcare Institute Ltd Ordinary SharesEquity62.55 Cr2.71%
Zydus Lifesciences LtdEquity58.36 Cr2.52%
Syngene International LtdEquity53.86 Cr2.33%
Alkem Laboratories LtdEquity44.71 Cr1.93%
Ajanta Pharma LtdEquity41.84 Cr1.81%
Ipca Laboratories LtdEquity37.23 Cr1.61%
Mankind Pharma LtdEquity35.92 Cr1.55%
Wockhardt LtdEquity33.2 Cr1.44%
Dr. Lal PathLabs LtdEquity32.89 Cr1.42%
Max Financial Services LtdEquity28.92 Cr1.25%
TrepsCash - Repurchase Agreement27.43 Cr1.19%
Biocon LtdEquity26.82 Cr1.16%
Natco Pharma LtdEquity25.28 Cr1.09%
Sanofi India LtdEquity17.43 Cr0.75%
Sanofi Consumer HeEquity10.12 Cr0.44%
Net Receivables / (Payables)Cash-0.57 Cr0.02%
Mirae Asset Liquid Dir GrMutual Fund - Open End0.21 Cr0.01%
Vinati Organics LtdEquity0.08 Cr0.00%
Laurus Labs LtdEquity0 Cr0.00%

Allocation By Market Cap (Equity)

Large Cap Stocks

45.91%

Mid Cap Stocks

40.50%

Small Cap Stocks

11.99%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare2,246.29 Cr97.14%
Financial Services28.92 Cr1.25%
Basic Materials0.08 Cr0.00%

Risk & Performance Ratios

Standard Deviation

This fund

14.67%

Cat. avg.

14.65%

Lower the better

Sharpe Ratio

This fund

0.55

Cat. avg.

0.55

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

0.92

Higher the better

Fund Managers

Vrijesh Kasera

Vrijesh Kasera

Since July 2018

Additional Scheme Detailsas of 30th June 2024

ISIN
INF769K01EA2
Expense Ratio
1.97%
Exit Load
1.00%
Fund Size
₹2,312 Cr
Age
02 Jun 2018
Lumpsum Minimum
₹5,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Withdrawal within 1 year

Flat 15% tax on realised gains (STCG - short term capital gains)

Withdrawal after 1 year

10% tax on realised gains above Rs. 1 lakh per financial year (LTCG - long term capital gains)

Note: Mutual funds are subject to capital gains taxation with surcharge and cess, based on prevailing income tax rules and investor income. Taxation applies to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹15.00 Cr46.4%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

1.0%1.0%₹713.42 Cr48.3%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹713.42 Cr46.2%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹29.73 Cr44.9%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.4%1.0%₹173.47 Cr44.4%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹173.47 Cr41.6%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2312.48 Cr46.0%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

2.0%1.0%₹2312.48 Cr43.8%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹638.88 Cr46.5%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹17.23 Cr43.8%

About the AMC

Total AUM

₹1,73,546 Cr

Address

Unit No. 606, 6th Floor, Mumbai, 400 098

Other Funds by Mirae Asset India Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
Mirae Asset Multi Asset Allocation Fund Direct Growth

High Risk

0.4%1.0%₹1524.79 Cr-
Mirae Asset Great Consumer Fund Direct Growth

Very High Risk

0.4%1.0%₹3751.14 Cr38.8%
Mirae Asset Cash Management Direct Growth

Low to Moderate Risk

0.1%0.0%₹10728.82 Cr7.4%
Mirae Asset Emerging Bluechip Direct Growth

Very High Risk

0.6%1.0%₹37846.07 Cr39.7%
Mirae Asset Large Cap Fund Direct Growth

Very High Risk

0.5%1.0%₹39951.46 Cr27.0%
Mirae Asset Savings Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹616.30 Cr7.6%
Mirae Asset Money Market Fund Direct Growth

Moderate Risk

0.2%0.0%₹139.18 Cr7.6%
Mirae Asset Focused Fund Direct Growth

Very High Risk

0.6%1.0%₹8255.25 Cr21.7%
Mirae Asset Dynamic Bond Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹146.35 Cr7.3%
Mirae Asset NYSE FANG+ ETF Fund of Fund Direct Growth

Very High Risk

0.1%0.0%₹1510.97 Cr50.9%
Mirae Asset Hybrid Equity Fund Direct Growth

Very High Risk

0.4%1.0%₹8962.66 Cr26.7%
Mirae Asset Equity Allocator Fund of Fund Direct Growth

Very High Risk

0.0%0.0%₹837.40 Cr34.5%
Mirae Asset Nifty 100 ESG Sector Leaders Fund of Fund Direct Growth

Very High Risk

0.1%0.0%₹110.62 Cr30.1%
Mirae Asset S&P 500 Top 50 ETF Fund of Fund Direct Growth

Very High Risk

0.1%0.0%₹539.13 Cr36.2%
Mirae Asset Nifty SDL Jun 2027 Index Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹800.19 Cr7.6%
Mirae Asset Ultra Short Duration Fund Direct Growth

Moderate Risk

0.2%0.0%₹1672.07 Cr7.7%
Mirae Asset Flexi Cap Fund Direct Growth

Very High Risk

0.6%1.0%₹2072.15 Cr31.2%
Mirae Asset Banking and Financial Services Fund Direct Growth

Very High Risk

0.6%1.0%₹1822.75 Cr22.2%
Mirae Asset Multicap Fund Direct Growth

Very High Risk

0.4%1.0%₹3120.86 Cr-
Mirae Asset Nifty India Manufacturing ETF Fund of Fund Direct Growth

Very High Risk

0.1%0.0%₹103.28 Cr53.6%
Mirae Asset Tax Saver Fund Direct Growth

Very High Risk

0.6%0.0%₹24345.83 Cr36.8%
Mirae Asset Nifty SDL Jun 2028 Index Fund Direct Growth

Moderate Risk

0.1%0.0%₹77.19 Cr7.4%
Mirae Asset Corporate Bond Fund Direct Growth

Moderate Risk

0.2%0.0%₹44.56 Cr7.2%
Mirae Asset Hang Seng TECH ETF Fund of Fund Direct Growth

Very High Risk

0.1%0.0%₹72.44 Cr-5.4%
Mirae Asset Equity Savings Fund Direct Growth

Moderately High risk

0.3%1.0%₹1126.87 Cr17.7%
Mirae Asset Banking and PSU Debt Fund Direct Growth

Moderate Risk

0.4%0.0%₹58.89 Cr7.2%
Mirae Asset Global X Artificial Intelligence & Technology ETF Fund of Fund Direct Growth

Very High Risk

0.3%1.0%₹333.10 Cr27.0%
Mirae Asset Global Electric & Autonomous Vehicles ETFs Fund of Fund Direct Growth

Very High Risk

0.2%1.0%₹72.13 Cr-12.1%
Mirae Asset Overnight Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹989.80 Cr6.9%
Mirae Asset Short Term Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹336.75 Cr7.5%
Mirae Asset CRISIL IBX Gilt Index - April 2033 Index Fund Direct Growth

Moderate Risk

0.1%0.0%₹231.20 Cr7.7%
Mirae Asset Nifty AAA PSU Bond Plus SDL Apr 2026 50:50 Index Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹88.92 Cr7.3%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2312.48 Cr46.0%
Mirae Asset Arbitrage Fund Direct Growth

Low Risk

0.2%0.0%₹2114.07 Cr8.7%
Mirae Asset Midcap Fund Direct Growth

Very High Risk

0.6%1.0%₹16667.30 Cr48.2%
Mirae Asset Balanced Advantage Fund Direct Growth

High Risk

0.7%1.0%₹1655.04 Cr21.6%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of Mirae Asset Healthcare Fund Regular Growth, as of 24-Jul-2024, is ₹34.79.
The fund has generated 43.83% over the last 1 year and 14.40% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 98.83% in equities, 0.00% in bonds, and 1.16% in cash and cash equivalents.
The fund managers responsible for Mirae Asset Healthcare Fund Regular Growth are:-
  1. Vrijesh Kasera